A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders-Reference-Cited by-同舟云学术

A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders

Published:2016-10 Issue: Volume:312 Page:148-162
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Grasing Kenneth

Funder

National Institutes of Health, Institute on Drug Abuse

Medical Research Service, Department of Veterans Affairs

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference213 articles.

1. Looking below the surface of nicotinic acetylcholine receptors;Stokes;Trends Pharmacol. Sci.,2015

2. Muscarinic acetylcholine receptors as CNS drug targets;Langmead;Pharmacol. Ther.,2008

3. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders;Lester;CNS Neurosci. Ther.,2010

4. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems;Zhou;Neuroscientist,2003

5. Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging;Bentley;Prog. Neurobiol.,2011

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct cholinergic circuits underlie discrete effects of reward on attention;Frontiers in Molecular Neuroscience;2024-08-29

2. Susceptibility to arecoline in male C57BL/6 J mice correlates with age factor;Behavioural Brain Research;2023-07

3. Selective Modulation of Hippocampal Theta Oscillations in Response to Morphine versus Natural Reward;Brain Sciences;2023-02-14

4. M3 Receptor Pathway Stimulates Rapid Transcription of the CB1 Receptor Activation through Calcium Signalling and the CNR1 Gene Promoter;International Journal of Molecular Sciences;2023-01-09

5. Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders;Behavioural Pharmacology;2022-03-23